AssuredPartners Investment Advisors LLC Makes New $434,000 Investment in Healthpeak Properties, Inc. (NYSE:DOC)

AssuredPartners Investment Advisors LLC bought a new position in shares of Healthpeak Properties, Inc. (NYSE:DOC) in the 4th quarter, Holdings Channel.com reports. The institutional investor bought 21,422 shares of the real estate investment trust’s stock, valued at approximately $434,000.

Other institutional investors and hedge funds also recently modified their holdings of the company. State Street Corp acquired a new position in Healthpeak Properties during the third quarter valued at approximately $1,093,576,000. Geode Capital Management LLC bought a new position in shares of Healthpeak Properties during the third quarter worth $403,898,000. Principal Financial Group Inc. grew its holdings in shares of Healthpeak Properties by 2,113.5% in the 4th quarter. Principal Financial Group Inc. now owns 18,133,812 shares of the real estate investment trust’s stock valued at $367,575,000 after buying an additional 17,314,572 shares during the period. UBS AM a distinct business unit of UBS ASSET MANAGEMENT AMERICAS LLC bought a new stake in shares of Healthpeak Properties in the 3rd quarter valued at $175,697,000. Finally, JPMorgan Chase & Co. raised its stake in Healthpeak Properties by 23.2% during the 3rd quarter. JPMorgan Chase & Co. now owns 21,561,640 shares of the real estate investment trust’s stock worth $493,115,000 after buying an additional 4,056,931 shares during the period. 93.57% of the stock is owned by institutional investors.

Analyst Ratings Changes

Several equities research analysts have issued reports on the company. Wedbush lowered their price target on Healthpeak Properties from $27.00 to $24.00 and set an “outperform” rating for the company in a report on Friday, February 14th. Mizuho dropped their target price on shares of Healthpeak Properties from $25.00 to $24.00 and set an “outperform” rating on the stock in a report on Thursday, December 5th. Scotiabank reduced their price target on shares of Healthpeak Properties from $24.00 to $23.00 and set a “sector outperform” rating for the company in a report on Friday, February 28th. Wells Fargo & Company dropped their price objective on shares of Healthpeak Properties from $23.00 to $22.00 and set an “equal weight” rating on the stock in a report on Tuesday, December 10th. Finally, Robert W. Baird reduced their target price on shares of Healthpeak Properties from $25.00 to $24.00 and set an “outperform” rating for the company in a research note on Tuesday, February 11th. Four investment analysts have rated the stock with a hold rating, ten have issued a buy rating and one has given a strong buy rating to the company’s stock. According to MarketBeat.com, the stock presently has an average rating of “Moderate Buy” and an average target price of $23.92.

Healthpeak Properties Stock Down 0.4 %

NYSE:DOC opened at $20.24 on Friday. Healthpeak Properties, Inc. has a twelve month low of $17.80 and a twelve month high of $23.26. The firm has a market capitalization of $14.16 billion, a price-to-earnings ratio of 57.82, a price-to-earnings-growth ratio of 2.17 and a beta of 1.14. The company has a quick ratio of 1.35, a current ratio of 1.35 and a debt-to-equity ratio of 0.96. The stock’s 50 day moving average price is $20.24 and its two-hundred day moving average price is $21.12.

Healthpeak Properties Increases Dividend

The company also recently declared a quarterly dividend, which was paid on Wednesday, February 26th. Shareholders of record on Friday, February 14th were given a dividend of $0.305 per share. This is a positive change from Healthpeak Properties’s previous quarterly dividend of $0.30. This represents a $1.22 annualized dividend and a yield of 6.03%. The ex-dividend date of this dividend was Friday, February 14th. Healthpeak Properties’s dividend payout ratio is 348.57%.

About Healthpeak Properties

Healthpeak Properties, Inc is a fully integrated real estate investment trust (REIT) and S&P 500 company. Healthpeak owns, operates, and develops high-quality real estate for healthcare discovery and delivery.